Abstract
Pulmonary function tests are the gold standard for evaluating disease status and treatment response in persons with cystic fibrosis (CF). Pulmonary function, however, is an outcome influenced by multiple circumstances. Sweat chloride (SwCl) concentration is a reliable outcome, solely reflecting the activity of the CF transmembrane conductance regulator protein. In the present study, we aim to evaluate the effect of ETI treatment on SwCl concentration.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Paper Title
Journal
Date
